Featured,Shroom News Stephen Hurst Steps Down From MindMed’s Board of Directors By Dennis Mutua January 10, 2022 Biotechnology company developing and deploying psychedelic inspired medicines to treat addiction and mental conditions MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced Stephen Hurst has resigned from his position as a director to...
Psychedelic Stocks,Shroom News MindMed Announces Completion of Phase 1 Clinical Trial of 18-MC By Dennis Mutua January 05, 2022 Psychedelic medicine company focusing on discovering, developing and deploying psychedelic-inspired medicine to cure addiction and mental illnesses MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced having successfully completed ph...
Psychedelic Stocks,Shroom News Numinus Wellness Commends Health Canada for Amending SAP Allowing Access to Psychedelic Medicine By Dennis Mutua December 31, 2021 Mental health and wellness company combining the practice of administering psychedelic medicine with holistic integrated psychotherapy Numinus Wellness Inc. (TSX: NUMI) has applauded Health Canada for amending Special Access Progr...
Psychedelic Stocks,Shroom News HAVN Life Sciences Enters Into an Agreement to Acquire Spore Life Sciences By Dennis Mutua December 21, 2021 Biotechnology company focusing on psychedelic therapies for treatment HAVN Life Sciences Inc. (CSE: HAVN) (OTCMKTS: HAVLF) announced having entered into a definitive agreement to acquire all outstanding securities of Spore Life Sc...
Shroom News,Spotlight Stock HAVN Life Sciences Exports Psilocybin Form Jamaica to U.S for Research Purposes By Dennis Mutua December 14, 2021 Biotechnology company creating psychedelic supply chain through research, extraction, formulation and delivery of psychedelics HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) announced having successfully exported naturally extra...
Psychedelic Stocks,Shroom News Delix Partners With NIDA to Progress Research on Non-Hallucinogenic Therapies to Treat Substance Use Disorders By Dennis Mutua December 09, 2021 Medical research company developing small molecule drug compounds seeking to help provide treatment against mental health disorders Delix Therapeutics announced having entered into a partnership with the National Institute on Drug...
Psychedelic Stocks,Shroom News Mydecine Submits Patent Application Covering Multiple Families of Psilocybin Analogs By Dennis Mutua December 07, 2021 Biotechnology company focusing on developing innovative first and second generation novel therapeutics for treatment of addiction and mental health Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) has submitted a full patent ap...
Psychedelic Stocks,Shroom News Delic Holdings’ Subsidiary KWC Planning to Open 2 New Clinics in Reno and Salt Lake City By Dennis Mutua December 03, 2021 Ketamine Wellness Centers (KWC), a wholly owned subsidiary of psychedelics wellness company focusing on making psychedelics treatments more accessible Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) announced that it’s planning ...